Weiss M C, Baumgart E, Fahimi H D, Pill H, Rebel W, Hartig F
Abteilung für präklinische Forschung, Boehringer Mannheim.
Berl Munch Tierarztl Wochenschr. 1995 Feb;108(2):66-9.
Sprague-Dawley rats of both sexes were treated for three months with BM 15,766, an inhibitor of cholesterol biosynthesis in conjunction with standard or high-fat and high-cholesterol diets. In serum and livers of all drug-treated rats lowered cholesterol concentration associated with an increase of 7-dehydrocholesterol (7-DHC) was found. Electron microscopy of the liver showed a distinct proliferation of peroxisomes and an increase of dumb-bell shaped mitochondria in the pericentral zone 3. Abnormal-shaped peroxisomes with DAB-negative loops attached to their membranes were found in the intermediate zone 2. These alterations were more accentuated in drug-treated rats fed standard diet, then in treated rats receiving a high-fat and high-cholesterol diet. The observations demonstrate, that the increase of 7-DHC is due to the inhibition of 7-DHC-delta 7-reductase by BM 15.766 and emphasize the zonal heterogeneity of hepatocytes. The relevance of these observations for the investigation of the human Smith-Lemli-Opitz syndrome, in which also decreased plasma-cholesterol levels and an increase of 7-DHC were reported, is discussed.
将雄性和雌性Sprague-Dawley大鼠用胆固醇生物合成抑制剂BM 15,766与标准或高脂高胆固醇饮食联合处理三个月。在所有接受药物治疗的大鼠的血清和肝脏中,发现胆固醇浓度降低,同时7-脱氢胆固醇(7-DHC)增加。肝脏的电子显微镜检查显示,3区中央周围区域的过氧化物酶体明显增殖,哑铃形线粒体增加。在2区中间区域发现了形状异常的过氧化物酶体,其膜上附着有DAB阴性环。这些改变在喂食标准饮食的药物治疗大鼠中比在接受高脂高胆固醇饮食的治疗大鼠中更为明显。这些观察结果表明,7-DHC的增加是由于BM 15.766对7-DHC-δ7-还原酶的抑制作用,并强调了肝细胞的区域异质性。讨论了这些观察结果与人类史密斯-勒米-奥皮茨综合征研究的相关性,该综合征也报告了血浆胆固醇水平降低和7-DHC增加。